Literature DB >> 10487854

Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).

J A Doll1, X Zhu, J Furman, Z Kaleem, C Torres, P A Humphrey, H Donis-Keller.   

Abstract

Atypical adenomatous hyperplasia (AAH) of the prostate, a small glandular proliferation, is a putative precursor lesion to prostate cancer, in particular to the subset of well-differentiated carcinomas that arise in the transition zone, the same region where AAH lesions most often occur. Several morphological characteristics of AAH suggest a relationship to cancer; however, no definitive evidence has been reported. In this study, we analyzed DNA from 25 microdissected AAH lesions for allelic imbalance as compared to matched normal DNA, using one marker each from chromosome arms 1q, 6q, 7q, 10q, 13q, 16q, 17p, 17q, and 18q, and 19 markers from chromosome 8p. We observed 12% allelic imbalance, with loss only within chromosome 8p11-12. These results suggest that genetic alterations in transition zone AAH lesions may be infrequent. This genotypic profile of AAH will allow for comparisons with well-differentiated carcinomas in the transition zone of the prostate.

Entities:  

Mesh:

Year:  1999        PMID: 10487854      PMCID: PMC1866890          DOI: 10.1016/S0002-9440(10)65196-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?

Authors:  L Cheng; A Shan; J C Cheville; J Qian; D G Bostwick
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

2.  Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.

Authors:  T M Trybus; A C Burgess; K J Wojno; T W Glover; J A Macoska
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

3.  Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.

Authors:  X Gao; A Zacharek; D J Grignon; W Sakr; I J Powell; A T Porter; K V Honn
Journal:  Oncogene       Date:  1995-10-05       Impact factor: 9.867

4.  Distinct regions of allelic loss on 13q in prostate cancer.

Authors:  K A Cooney; J C Wetzel; S D Merajver; J A Macoska; T P Singleton; K J Wojno
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

5.  Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma.

Authors:  P N Brawn
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

6.  Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.

Authors:  J Qian; R B Jenkins; D G Bostwick
Journal:  Urology       Date:  1995-12       Impact factor: 2.649

7.  Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.

Authors:  B Helpap
Journal:  Pathol Res Pract       Date:  1995-09       Impact factor: 3.250

Review 8.  Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma.

Authors:  J I Epstein
Journal:  Pathol Res Pract       Date:  1995-09       Impact factor: 3.250

9.  Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread.

Authors:  J E McNeal; E A Redwine; F S Freiha; T A Stamey
Journal:  Am J Surg Pathol       Date:  1988-12       Impact factor: 6.394

10.  Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.

Authors:  M M Ittmann
Journal:  Prostate       Date:  1996-05       Impact factor: 4.104

View more
  7 in total

Review 1.  [Non-neoplastic alterations of the prostate. Why should pathologists know them?].

Authors:  A Erbersdobler
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

Review 2.  Precursor lesions to prostatic adenocarcinoma.

Authors:  Jonathan I Epstein
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

3.  High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.

Authors:  Debra L Zynger; Ximing Yang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-22

4.  Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.

Authors:  Roberta Mazzucchelli; Marina Scarpelli; Francesca Barbisan; Alfredo Santinelli; Antonio Lopez-Beltran; Liang Cheng; Rodolfo Montironi
Journal:  Cell Oncol (Dordr)       Date:  2012-11-07       Impact factor: 6.730

5.  Three-dimensional architecture of common benign and precancerous prostate epithelial lesions.

Authors:  Esther I Verhoef; Wiggert A van Cappellen; Johan A Slotman; Gert-Jan Kremers; Patricia C Ewing-Graham; Adriaan B Houtsmuller; Martin E van Royen; Geert J L H van Leenders
Journal:  Histopathology       Date:  2019-04-21       Impact factor: 5.087

6.  Atypical adenomatous hyperplasia (adenosis) of the prostate: a case report with review of the literature.

Authors:  Henry B Armah; Anil V Parwani
Journal:  Diagn Pathol       Date:  2008-08-12       Impact factor: 2.644

7.  Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma.

Authors:  Ahmet Midi; Tülay Tecimer; Süheyla Bozkurt; Naziye Ozkan
Journal:  Indian J Urol       Date:  2008-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.